The reclassification of asthma based on subphenotypes

被引:89
作者
Green, Ruth H. [1 ]
Brightling, Chris E. [1 ]
Bradding, Peter [1 ]
机构
[1] Glenfield Hosp, Dept Resp Med, Leicester LE3 9QP, Leics, England
关键词
asthma; classification; inflammation; phenotypes; refractory;
D O I
10.1097/ACI.0b013e3280118a32
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of review Despite asthma being widely regarded as a heterogeneous disease, a consensus for an accurate system of classification has not been agreed. Recent studies have suggested that the recognition of subphenotypes of asthma based on the pattern of airway inflammation may be particularly useful in increasing our understanding of the disease. The present review discusses the important literature in this field, placing current work in its historical context. Recent findings The use of noninvasive markers of airway inflammation has suggested the presence of four distinct phenotypes: eosinophilic, neutrophilic, mixed inflammatory and paucigranulocytic asthma. Recent studies suggest that these subgroups may differ in their aetiology, immunopathology and response to treatment. Several studies have focused on refractory asthma as a distinct phenotype with evidence of a more distal,pattern of airway inflammation and of upregulation of the tumour necrosis factor-a axis. Finally, novel treatment approaches targeted at specific patterns of airway inflammation are emerging, making an appreciation of subphenotypes particularly relevant. Summary The present review will discuss limitations to current classification systems, identify key current studies based on identifying inflammatory subphenotypes and provide suggestions for a novel approach that may further improve our understanding in this area.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 46 条
[1]   Brittle asthma [J].
Ayres, JG ;
Miles, JF ;
Barnes, PJ .
THORAX, 1998, 53 (04) :315-321
[2]   IDENTIFICATION OF LYMPHOCYTES-T, MACROPHAGES, AND ACTIVATED EOSINOPHILS IN THE BRONCHIAL-MUCOSA IN INTRINSIC ASTHMA - RELATIONSHIP TO SYMPTOMS AND BRONCHIAL RESPONSIVENESS [J].
BENTLEY, AM ;
MENZ, G ;
STORZ, C ;
ROBINSON, DS ;
BRADLEY, B ;
JEFFERY, PK ;
DURHAM, SR ;
KAY, AB .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (02) :500-506
[3]   Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma [J].
Berry, M ;
Hargadon, B ;
Morgan, A ;
Shelley, M ;
Richter, J ;
Shaw, D ;
Green, RH ;
Brightling, C ;
Wardlaw, AJ ;
Pavord, ID .
EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (06) :986-991
[4]   The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma [J].
Bousquet, J ;
Cabrera, P ;
Berkman, N ;
Buhl, R ;
Holgate, S ;
Wenzel, S ;
Fox, H ;
Hedgecock, S ;
Blogg, M ;
Della Cioppa, G .
ALLERGY, 2005, 60 (03) :302-308
[5]   EOSINOPHILIC INFLAMMATION IN ASTHMA [J].
BOUSQUET, J ;
CHANEZ, P ;
LACOSTE, JY ;
BARNEON, G ;
GHAVANIAN, N ;
ENANDER, I ;
VENGE, P ;
AHLSTEDT, S ;
SIMONYLAFONTAINE, J ;
GODARD, P ;
MICHEL, FB .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (15) :1033-1039
[6]   Clinical applications of induced sputum [J].
Brightling, CE .
CHEST, 2006, 129 (05) :1344-1348
[7]   Mast-cell infiltration of airway smooth muscle in asthma [J].
Brightling, CE ;
Bradding, P ;
Symon, FA ;
Holgate, ST ;
Wardlaw, AJ ;
Pavord, ID .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (22) :1699-1705
[8]  
*BRIT THOR SOC, 2003, THORAX S1, V5, P1
[9]   EVIDENCE OF ONGOING MAST-CELL AND EOSINOPHIL DEGRANULATION IN SYMPTOMATIC ASTHMA AIRWAY [J].
BROIDE, DH ;
GLEICH, GJ ;
CUOMO, AJ ;
COBURN, DA ;
FEDERMAN, EC ;
SCHWARTZ, LB ;
WASSERMAN, SI .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 88 (04) :637-648
[10]   Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma [J].
Busse, W ;
Corren, J ;
Lanier, BQ ;
McAlary, M ;
Fowler-Taylor, A ;
Della Cioppa, G ;
van As, A ;
Gupta, N .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (02) :184-190